Abstract
BackgroundCompared to traditional therapies for advanced malignancies, adoptive T cell transfer (ACT) therapy has increased the number of patients who achieve complete regressions; however, only about 20% of patients achieve...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
